お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はクローン病市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはクローン病の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のクローン病市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはクローン病のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にクローン病市場を分類しています。本研究に含まれる主な企業は：Abbvie、Amgen、Cambridge Antibody Technology、Janssen Biotech、Pfizer、Tillotts Pharma、Johnson & Johnson、Boehringer Ingelheim

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Surgery
    Drug Therapy

用途別の市場セグメント：
    Hospitals
    Ambulatory Surgical Centers
    Others

本レポートの詳細内容
世界のクローン病市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、クローン病タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のクローン病収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のクローン病市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、クローン病市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

クローン病のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：クローン病のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：クローン病の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章クローン病企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：クローン病の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：クローン病の主要企業の概要を提供し、製品の説明と仕様、クローン病の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Crohn’s disease develop slowly and gradually. Some of the common symptoms of this disease include abdominal pain and cramping, fever, fatigue, diarrhea, blood in stools, appetite and weight loss. Inflammation of skin, joints, and eyes, inflammation of the liver or bile duct, and delayed sexual development in children are some other symptoms associated with severe Crohn’s disease.
Market Analysis and Insights: Global Crohn's Disease Market
The global Crohn's Disease market is projected to grow from US$ 9185.2 million in 2024 to US$ 11030 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Rising number of drug therapies for Crohn’s disease and increasing demand for better diagnostics and treatment options for the auto-immune disease are some of the key factors driving the growth of the global Crohn’s disease market. In addition, rise in the number of patients suffering from auto-immune disorders in developing countries and increasing government initiatives for improving health care infrastructure are fueling the growth of the global Crohn’s disease market. However, less awareness among people about the disease is also restraining the growth of the market. Patent expiry of various useful drugs, such as remicade and humira, is also impeding the growth of the market.
Report Covers:
This report presents an overview of global market for Crohn's Disease market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Crohn's Disease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Crohn's Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Crohn's Disease revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Crohn's Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Crohn's Disease revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbvie, Amgen, Cambridge Antibody Technology, Janssen Biotech, Pfizer, Tillotts Pharma, Johnson & Johnson and Boehringer Ingelheim, etc.

Market Segmentation
By Company
    Abbvie
    Amgen
    Cambridge Antibody Technology
    Janssen Biotech
    Pfizer
    Tillotts Pharma
    Johnson & Johnson
    Boehringer Ingelheim

Segment by Type
    Surgery
    Drug Therapy

Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Crohn's Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn's Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crohn's Disease revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Crohn's Disease Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Surgery
    Table 3. Key Players of Drug Therapy
    Table 4. Global Crohn's Disease Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Crohn's Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Crohn's Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Crohn's Disease Market Share by Region (2019-2024)
    Table 8. Global Crohn's Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Crohn's Disease Market Share by Region (2025-2030)
    Table 10. Crohn's Disease Market Trends
    Table 11. Crohn's Disease Market Drivers
    Table 12. Crohn's Disease Market Challenges
    Table 13. Crohn's Disease Market Restraints
    Table 14. Global Crohn's Disease Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Crohn's Disease Revenue Share by Players (2019-2024)
    Table 16. Global Top Crohn's Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn's Disease as of 2023)
    Table 17. Global Crohn's Disease Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Crohn's Disease Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Crohn's Disease, Headquarters and Area Served
    Table 20. Global Key Players of Crohn's Disease, Product and Application
    Table 21. Global Key Players of Crohn's Disease, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Crohn's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Crohn's Disease Revenue Market Share by Type (2019-2024)
    Table 25. Global Crohn's Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Crohn's Disease Revenue Market Share by Type (2025-2030)
    Table 27. Global Crohn's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Crohn's Disease Revenue Share by Application (2019-2024)
    Table 29. Global Crohn's Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Crohn's Disease Revenue Share by Application (2025-2030)
    Table 31. North America Crohn's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Crohn's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Crohn's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Crohn's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Crohn's Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Crohn's Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Crohn's Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Crohn's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Crohn's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Crohn's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Crohn's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Crohn's Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Crohn's Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Crohn's Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Crohn's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Crohn's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Crohn's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Crohn's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Crohn's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Crohn's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Crohn's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Crohn's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Crohn's Disease Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Crohn's Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Crohn's Disease Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Crohn's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Crohn's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Crohn's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Crohn's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Crohn's Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Crohn's Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Crohn's Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Abbvie Company Details
    Table 64. Abbvie Business Overview
    Table 65. Abbvie Crohn's Disease Product
    Table 66. Abbvie Revenue in Crohn's Disease Business (2019-2024) & (US$ Million)
    Table 67. Abbvie Recent Developments
    Table 68. Amgen Company Details
    Table 69. Amgen Business Overview
    Table 70. Amgen Crohn's Disease Product
    Table 71. Amgen Revenue in Crohn's Disease Business (2019-2024) & (US$ Million)
    Table 72. Amgen Recent Developments
    Table 73. Cambridge Antibody Technology Company Details
    Table 74. Cambridge Antibody Technology Business Overview
    Table 75. Cambridge Antibody Technology Crohn's Disease Product
    Table 76. Cambridge Antibody Technology Revenue in Crohn's Disease Business (2019-2024) & (US$ Million)
    Table 77. Cambridge Antibody Technology Recent Developments
    Table 78. Janssen Biotech Company Details
    Table 79. Janssen Biotech Business Overview
    Table 80. Janssen Biotech Crohn's Disease Product
    Table 81. Janssen Biotech Revenue in Crohn's Disease Business (2019-2024) & (US$ Million)
    Table 82. Janssen Biotech Recent Developments
    Table 83. Pfizer Company Details
    Table 84. Pfizer Business Overview
    Table 85. Pfizer Crohn's Disease Product
    Table 86. Pfizer Revenue in Crohn's Disease Business (2019-2024) & (US$ Million)
    Table 87. Pfizer Recent Developments
    Table 88. Tillotts Pharma Company Details
    Table 89. Tillotts Pharma Business Overview
    Table 90. Tillotts Pharma Crohn's Disease Product
    Table 91. Tillotts Pharma Revenue in Crohn's Disease Business (2019-2024) & (US$ Million)
    Table 92. Tillotts Pharma Recent Developments
    Table 93. Johnson & Johnson Company Details
    Table 94. Johnson & Johnson Business Overview
    Table 95. Johnson & Johnson Crohn's Disease Product
    Table 96. Johnson & Johnson Revenue in Crohn's Disease Business (2019-2024) & (US$ Million)
    Table 97. Johnson & Johnson Recent Developments
    Table 98. Boehringer Ingelheim Company Details
    Table 99. Boehringer Ingelheim Business Overview
    Table 100. Boehringer Ingelheim Crohn's Disease Product
    Table 101. Boehringer Ingelheim Revenue in Crohn's Disease Business (2019-2024) & (US$ Million)
    Table 102. Boehringer Ingelheim Recent Developments
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Crohn's Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Crohn's Disease Market Share by Type: 2023 VS 2030
    Figure 3. Surgery Features
    Figure 4. Drug Therapy Features
    Figure 5. Global Crohn's Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Crohn's Disease Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Ambulatory Surgical Centers Case Studies
    Figure 9. Others Case Studies
    Figure 10. Crohn's Disease Report Years Considered
    Figure 11. Global Crohn's Disease Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Crohn's Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Crohn's Disease Market Share by Region: 2023 VS 2030
    Figure 14. Global Crohn's Disease Market Share by Players in 2023
    Figure 15. Global Top Crohn's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn's Disease as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Crohn's Disease Revenue in 2023
    Figure 17. North America Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Crohn's Disease Market Share by Type (2019-2030)
    Figure 19. North America Crohn's Disease Market Share by Application (2019-2030)
    Figure 20. North America Crohn's Disease Market Share by Country (2019-2030)
    Figure 21. United States Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Crohn's Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Crohn's Disease Market Share by Type (2019-2030)
    Figure 25. Europe Crohn's Disease Market Share by Application (2019-2030)
    Figure 26. Europe Crohn's Disease Market Share by Country (2019-2030)
    Figure 27. Germany Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Crohn's Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Crohn's Disease Market Share by Type (2019-2030)
    Figure 35. China Crohn's Disease Market Share by Application (2019-2030)
    Figure 36. Asia Crohn's Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Crohn's Disease Market Share by Type (2019-2030)
    Figure 38. Asia Crohn's Disease Market Share by Application (2019-2030)
    Figure 39. Asia Crohn's Disease Market Share by Region (2019-2030)
    Figure 40. Japan Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Crohn's Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Crohn's Disease Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Crohn's Disease Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Crohn's Disease Market Share by Country (2019-2030)
    Figure 50. Brazil Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Crohn's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Abbvie Revenue Growth Rate in Crohn's Disease Business (2019-2024)
    Figure 57. Amgen Revenue Growth Rate in Crohn's Disease Business (2019-2024)
    Figure 58. Cambridge Antibody Technology Revenue Growth Rate in Crohn's Disease Business (2019-2024)
    Figure 59. Janssen Biotech Revenue Growth Rate in Crohn's Disease Business (2019-2024)
    Figure 60. Pfizer Revenue Growth Rate in Crohn's Disease Business (2019-2024)
    Figure 61. Tillotts Pharma Revenue Growth Rate in Crohn's Disease Business (2019-2024)
    Figure 62. Johnson & Johnson Revenue Growth Rate in Crohn's Disease Business (2019-2024)
    Figure 63. Boehringer Ingelheim Revenue Growth Rate in Crohn's Disease Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed